CDNA - CareDx, Inc

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
15.78
-0.01 (-0.06%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close15.79
Open15.82
Bid0.00 x 800
Ask0.00 x 1300
Day's Range15.54 - 16.00
52 Week Range1.04 - 16.00
Volume444,387
Avg. Volume516,451
Market Cap556.769M
Beta0.36
PE Ratio (TTM)N/A
EPS (TTM)-2.32
Earnings DateAug 8, 2017 - Aug 14, 2017
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est14.67
Trade prices are not sourced from all markets
  • GlobeNewswire14 days ago

    CareDx Promotes Living Donor Transplantation Through Employee Policy

    CareDx, Inc. (CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients, announces a progressive Living Donor Employee Recovery Policy to support employees who donate an organ or bone marrow. As part of the company’s commitment to the organ transplant community, CareDx will adopt a corporate policy to support employees who donate an organ or bone marrow to help save someone's life. The Living Donor Employee Recovery Policy was announced at the American Transplant Congress in Seattle, Washington alongside a presentation on the importance of living organ donation from Kevin Longino, CEO of the National Kidney Foundation.

  • GlobeNewswire18 days ago

    Key CareDx Events Scheduled at American Transplant Congress 2018

    BRISBANE, Calif., June 01, 2018-- CareDx, Inc., a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions ...

  • GlobeNewswire26 days ago

    CareDx to Hold Press Conference at American Transplant Congress

    BRISBANE, Calif., May 24, 2018-- CareDx, Inc., a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions ...

  • Thomson Reuters StreetEventslast month

    Edited Transcript of CDNA earnings conference call or presentation 10-May-18 8:30pm GMT

    Q1 2018 CareDx Inc Earnings Call

  • Best Growth Stocks To Buy Now
    Simply Wall St.last month

    Best Growth Stocks To Buy Now

    High growth companies such as Fanhua and CareDx has a positive future outlook in terms of their returns, profitability and cash flows. The prospects of these companies tend to outperformRead More...

  • Associated Presslast month

    CareDx: 1Q Earnings Snapshot

    On a per-share basis, the Brisbane, California-based company said it had a loss of 30 cents. The molecular diagnostics company posted revenue of $14.1 million in the period, which topped Street forecasts. ...

  • GlobeNewswirelast month

    CareDx Reports First Quarter Results

    AlloSure launch momentum drives 21% revenue growth. Further expands product offerings for transplant patients. BRISBANE, Calif., May 10, 2018-- CareDx, Inc., a molecular diagnostics company focused on ...

  • GlobeNewswirelast month

    CareDx expands NGS Transplant Product Offerings

    BRISBANE, Calif., May 09, 2018-- CareDx, today announced that, as reported in its Current Report on Form 8- K filed with the Securities Exchange Commission on May 8, 2018, it entered into a License and ...

  • GlobeNewswire2 months ago

    CareDx Activities at American Transplant Congress

    BRISBANE, Calif., May 01, 2018-- CareDx, Inc., a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions ...

  • ACCESSWIRE2 months ago

    Free Post Earnings Research Report: CareDx’s Quarterly Sales Rose 15%; Adjusted Net Loss Narrowed

    LONDON, UK / ACCESSWIRE / April 25, 2018 / Active-Investors.com has just released a free earnings report on CareDx, Inc (NASDAQ: CDNA ). If you want access to this report all you need to do is sign up ...

  • GlobeNewswire2 months ago

    CareDx to Announce First Quarter 2018 Financial Results on May 10, 2018

    BRISBANE, Calif., April 20, 2018-- CareDx, Inc., a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions ...

  • GlobeNewswire2 months ago

    CareDx Closes Debt Refinancing

    CareDx, Inc. (CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients, today announced that it has closed its debt refinancing by entering into a credit agreement with Perceptive Advisors, which provided an initial term loan of $15 million. The term loan facility consists of an initial tranche of $15 million, with a second tranche of $10 million available at the Company’s option over the next twelve months, subject to the satisfaction of customary conditions. The proceeds from the initial tranche will be used to repay the Company’s $11.1 million debt obligation to Danske Bank and the Allenex former majority shareholders, as well as for general corporate purposes.

  • GlobeNewswire2 months ago

    Olerup QTYPE® Receives CE Mark Certification

    BRISBANE, Calif., April 13, 2018-- CareDx, Inc., a molecular diagnostics company focused on the discovery, development, and commercialization of clinically differentiated, high-value diagnostic solutions ...

  • GlobeNewswire2 months ago

    CareDx Launches HeartCare® for Heart Transplant Recipients

    BRISBANE, Calif., April 10, 2018-- CareDx, Inc., a molecular diagnostics company focused on the discovery, development, and commercialization of clinically differentiated, high-value diagnostic solutions ...

  • ACCESSWIRE2 months ago

    Wired News – Myriad Genetics Receives Japanese Regulatory Approval for BRACAnalysis(R) Diagnostic System

    Stock Monitor: CareDx Post Earnings Reporting LONDON, UK / ACCESSWIRE / April 04, 2018 / Active-Investors.com has just released a free research report on Myriad Genetics, Inc. (NASDAQ: MYGN ) ("Myriad"). ...

  • GlobeNewswire3 months ago

    CareDx Announces Completion of Debt Conversion

    BRISBANE, Calif., March 29, 2018-- CareDx, Inc., a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions ...

  • Thomson Reuters StreetEvents3 months ago

    Edited Transcript of CDNA earnings conference call or presentation 22-Mar-18 8:30pm GMT

    Q4 2017 CareDx Inc Earnings Call

  • Associated Press3 months ago

    CareDx reports 4Q loss

    On a per-share basis, the Brisbane, California-based company said it had a loss of $1.13. Losses, adjusted for non-recurring costs and stock option expense, came to 9 cents per share. The molecular diagnostics ...

  • GlobeNewswire3 months ago

    CareDx Reports Fourth Quarter and FY2017 Financial Results

    47 Transplantation Centers Offering AlloSure. 9 Centers Enrolled in K-OAR. BRISBANE, Calif., March 22, 2018-- CareDx, Inc., a molecular diagnostics company focused on the discovery, development and commercialization ...

  • ACCESSWIRE3 months ago

    CareDx, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / March 22, 2018 / CareDx, Inc. (NASDAQ: CDNA ) will be discussing their earnings results in their Q4 Earnings Call to be held on March 22, 2018, at 4:30 PM Eastern Time. To listen ...